Cargando…

Melioidosis–a disease of socioeconomic disadvantage

BACKGROUND: There is growing recognition of the contribution of the social determinants of health to the burden of many infectious diseases. However, the relationship between socioeconomic status and the incidence and outcome of melioidosis is incompletely defined. METHODS: All residents of Far Nort...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanson, Josh, Smith, Simon, Stewart, James, Horne, Peter, Ramsamy, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248627/
https://www.ncbi.nlm.nih.gov/pubmed/34153059
http://dx.doi.org/10.1371/journal.pntd.0009544
_version_ 1783716761970933760
author Hanson, Josh
Smith, Simon
Stewart, James
Horne, Peter
Ramsamy, Nicole
author_facet Hanson, Josh
Smith, Simon
Stewart, James
Horne, Peter
Ramsamy, Nicole
author_sort Hanson, Josh
collection PubMed
description BACKGROUND: There is growing recognition of the contribution of the social determinants of health to the burden of many infectious diseases. However, the relationship between socioeconomic status and the incidence and outcome of melioidosis is incompletely defined. METHODS: All residents of Far North Queensland, tropical Australia with culture-proven melioidosis between January 1998 and December 2020 were eligible for the study. Their demographics, comorbidities and socioeconomic status were correlated with their clinical course. Socioeconomic status was determined using the Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-economic Disadvantage score, a measure of socioeconomic disadvantage developed by the Australian Bureau of Statistics. Socioeconomic disadvantage was defined as residence in a region with a SEIFA score in the lowest decile in Australia. RESULTS: 321 eligible individuals were diagnosed with melioidosis during the study period, 174 (54.2%) identified as Indigenous Australians; 223/321 (69.5%) were bacteraemic, 85/321 (26.5%) required Intensive Care Unit (ICU) admission and 37/321 (11.5%) died. 156/321 (48.6%) were socioeconomically disadvantaged, compared with 56603/269002 (21.0%) of the local general population (p<0.001). Socioeconomically disadvantaged patients were younger, more likely to be female, Indigenous, diabetic or have renal disease. They were also more likely to die prior to hospital discharge (26/156 (16.7%) versus 11/165 (6.7%), p = 0.002) and to die at a younger age (median (IQR) age: 50 (38–68) versus 65 (59–81) years, p = 0.02). In multivariate analysis that included age, Indigenous status, the presence of bacteraemia, ICU admission and the year of hospitalisation, only socioeconomic disadvantage (odds ratio (OR) (95% confidence interval (CI)): 2.49 (1.16–5.35), p = 0.02) and ICU admission (OR (95% CI): 4.79 (2.33–9.86), p<0.001) were independently associated with death. CONCLUSION: Melioidosis is disease of socioeconomic disadvantage. A more holistic approach to the delivery of healthcare which addresses the social determinants of health is necessary to reduce the burden of this life-threatening disease.
format Online
Article
Text
id pubmed-8248627
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-82486272021-07-09 Melioidosis–a disease of socioeconomic disadvantage Hanson, Josh Smith, Simon Stewart, James Horne, Peter Ramsamy, Nicole PLoS Negl Trop Dis Research Article BACKGROUND: There is growing recognition of the contribution of the social determinants of health to the burden of many infectious diseases. However, the relationship between socioeconomic status and the incidence and outcome of melioidosis is incompletely defined. METHODS: All residents of Far North Queensland, tropical Australia with culture-proven melioidosis between January 1998 and December 2020 were eligible for the study. Their demographics, comorbidities and socioeconomic status were correlated with their clinical course. Socioeconomic status was determined using the Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-economic Disadvantage score, a measure of socioeconomic disadvantage developed by the Australian Bureau of Statistics. Socioeconomic disadvantage was defined as residence in a region with a SEIFA score in the lowest decile in Australia. RESULTS: 321 eligible individuals were diagnosed with melioidosis during the study period, 174 (54.2%) identified as Indigenous Australians; 223/321 (69.5%) were bacteraemic, 85/321 (26.5%) required Intensive Care Unit (ICU) admission and 37/321 (11.5%) died. 156/321 (48.6%) were socioeconomically disadvantaged, compared with 56603/269002 (21.0%) of the local general population (p<0.001). Socioeconomically disadvantaged patients were younger, more likely to be female, Indigenous, diabetic or have renal disease. They were also more likely to die prior to hospital discharge (26/156 (16.7%) versus 11/165 (6.7%), p = 0.002) and to die at a younger age (median (IQR) age: 50 (38–68) versus 65 (59–81) years, p = 0.02). In multivariate analysis that included age, Indigenous status, the presence of bacteraemia, ICU admission and the year of hospitalisation, only socioeconomic disadvantage (odds ratio (OR) (95% confidence interval (CI)): 2.49 (1.16–5.35), p = 0.02) and ICU admission (OR (95% CI): 4.79 (2.33–9.86), p<0.001) were independently associated with death. CONCLUSION: Melioidosis is disease of socioeconomic disadvantage. A more holistic approach to the delivery of healthcare which addresses the social determinants of health is necessary to reduce the burden of this life-threatening disease. Public Library of Science 2021-06-21 /pmc/articles/PMC8248627/ /pubmed/34153059 http://dx.doi.org/10.1371/journal.pntd.0009544 Text en © 2021 Hanson et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hanson, Josh
Smith, Simon
Stewart, James
Horne, Peter
Ramsamy, Nicole
Melioidosis–a disease of socioeconomic disadvantage
title Melioidosis–a disease of socioeconomic disadvantage
title_full Melioidosis–a disease of socioeconomic disadvantage
title_fullStr Melioidosis–a disease of socioeconomic disadvantage
title_full_unstemmed Melioidosis–a disease of socioeconomic disadvantage
title_short Melioidosis–a disease of socioeconomic disadvantage
title_sort melioidosis–a disease of socioeconomic disadvantage
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248627/
https://www.ncbi.nlm.nih.gov/pubmed/34153059
http://dx.doi.org/10.1371/journal.pntd.0009544
work_keys_str_mv AT hansonjosh melioidosisadiseaseofsocioeconomicdisadvantage
AT smithsimon melioidosisadiseaseofsocioeconomicdisadvantage
AT stewartjames melioidosisadiseaseofsocioeconomicdisadvantage
AT hornepeter melioidosisadiseaseofsocioeconomicdisadvantage
AT ramsamynicole melioidosisadiseaseofsocioeconomicdisadvantage